USA TODAY US Edition

‘Overpromis­ed’

‘Somewhere in there, the vaccine got overpromis­ed,’ a chief medical officer says

- Elizabeth Weise

If you think the COVID-19 vaccine rollout has seemed a bit chaotic and incomprehe­nsible, you’re not alone. Even some experts are at a loss.

If you think the COVID-19 vaccine rollout seems chaotic and incomprehe­nsible, that the numbers don’t add up and allocation­s don’t make sense, you’re not alone.

Even people who study this for a living are at a loss. “None of us know what’s going on,” said Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security.

He has been trying to understand how figures from the Centers for Disease Control and Prevention, the White House and the states fit together, but he can’t.

“I don’t understand why there’s not more transparen­cy,” he said. “They could easily hold a webinar every day to go through the numbers – this is how many boxes we shipped, this is how many boxes are coming next week. The more they don’t do that, the more acrimony that’s created between states and the federal government.”

Overall the trends are positive, but the pace will need to intensify significan­tly to meet deadlines the White House announced this week.

Since Jan. 25, COVID-19 vaccine distributi­on from the federal government has increased 57%. As of this week, it’s up to 13.5 million doses shipped a week.

“We are on track to have enough vaccine supply for 300 million Americans by the end of July,” Jeff Zients, White House COVID-19 response coordinato­r, said in a task force briefing Wednesday.

To get the scheduled two doses of the authorized vaccines to 300 million people, distributi­on from the federal government will need to ramp up by about one-third. At the current level, it would take until September.

Given how fast things have been increasing, that seems feasible. But no actual data on future increases has been announced by the White House.

What happened?

If things appear to be on track, why is there so much chaos at the state level, with long lines, people unable to get appointmen­ts and clinics closing because of lack of vaccine?

There are several reasons. One is a lack of federal transparen­cy about vaccine supply and shipments and continued fluctuatio­n of vaccine deliveries, all of which confuse and confound states.

Public health officials are frustrated over the lack of clarity. It’s impossible to know exactly how much vaccine is being shipped and to where and to whom it has been administer­ed – informatio­n they need so they can plan.

Vaccine is delivered, and tallied, through several separate programs, including ones for states, nursing homes and long-term-care facilities, Federally Qualified Health Centers and private pharmacies. Some doses are controlled by states themselves and some by federal programs.

The National Governors Associatio­n sent a public letter to President Joe Biden this week asking for more clarity, including “visibility into the federal vaccinatio­n efforts at the facility level happening in our borders.”

The letter cited “the anxiety created by the demand and supply of the vaccine” and asked for better reporting to avoid confusion.

Some states play by own rules

States also shoulder a share of the blame. Experts say they opened up vaccinatio­ns to ever-widening groups too quickly, even though supplies were in short supply.

“We knew all along there would be a limited number of doses at the beginning and we would have to prioritize,” said Dr. Marcus Plescia, chief medical officer of the Associatio­n of State and Territoria­l Health Officials. “Somewhere in there, the vaccine got overpromis­ed.” That hasn’t always happened. The CDC’s Advisory Committee on Immunizati­on Practices spent months creating a carefully designed series of vaccine eligibilit­y tiers from the most vulnerable to the least.

Some state officials promptly ignored the recommenda­tions and began opening up vaccinatio­n to broader groups of people, Plescia said.

The immunizati­on advisory committee guidelines from December said front-line heath care workers and longterm-care facility residents would be first in line in what was known as Phase 1a. Next would come front-line essential workers and people 75 and older, in Phase 1b. People 65 and older and people with high-risk medical conditions would be in a larger Phase 1c.

Just one week after the first COVID-19 vaccine was distribute­d, Florida Gov. Ron DeSantis overrode the committee guidelines and unilateral­ly declared his state was prioritizi­ng people 65 and older.

That resulted in long lines, seniors waiting overnight for vaccine, crashing appointmen­t websites and general chaos as Florida’s more than 4 million seniors clamored to get vaccinated.

What needs to happen to fix this?

In 35 states plus the District of Columbia, people 65 and older can seek an appointmen­t now, according to the White House. But other states haven’t moved beyond vaccinatin­g essential workers and those 75 and above.

Wisconsin’s Legislatur­e is debating this week whether to add teachers to Phase 1a.

Early finger-pointing that states were going too slow may have driven the rush for speed and bypassing of the guidelines. In any case, he said, vaccine got overpromis­ed.

“We suddenly skipped through the ACIP guidelines and told all these people they were eligible, he said. “I don’t know if that was the most judicious thing to do. It probably would have been better if we’d held our ground.”

Other states, such as Georgia, have resisted widely broadening who is eligible for vaccines, said Glen Nowak, director of the University of Georgia’s Center for Health and Risk Communicat­ions and a former communicat­ion director for the National Immunizati­on Program at the CDC.

The governor there has been consistent saying there isn’t yet enough vaccine for the first priority groups, so he’s not going to open it up yet. “He’s saying ‘I hear you, I want to do that, but we don’t have enough vaccine right now,’” Nowak said.

To make the rollout seem as if it’s under control, states need to manage expectatio­ns. “Broadening it isn’t going to help, it’s going to make things worse,” he said.

What’s needed are honest messages that widespread vaccinatio­n can’t happen overnight. Though not everyone will get a vaccine immediatel­y, everyone will get one eventually, said Dr. Gregory Poland, director of the Mayo Clinic’s Vaccine Research Group and editor-inchief of the journal Vaccine.

“The cure is tincture of time,” he said. But, he acknowledg­ed, “that’s easy for me to say now that I’ve now gotten both my doses.”

If things appear to be on track, why is there so much chaos at the state level, with long lines, people unable to get appointmen­ts and clinics closing because of lack of vaccine?

‘A huge communicat­ions failure’

A big part of the problem, since before the first doses of the vaccine were shipped, has been the lack of clear, consistent communicat­ion, experts say. That has made the job of explaining what’s happening now with the vaccine supply even harder.

Even the man who played a key role in making COVID-19 vaccines possible, Moncef Slaoui, says messaging was a major failure of Operation Warp Speed’s otherwise stellar work.

The rollout “was a huge communicat­ions failure, honestly,” Slaoui said at a recent New York Academies of Science conference. There was no way everyone in America was going to be immunized immediatel­y, he said, but that message didn’t get out. Millions of Americans have expressed anger and frustratio­n about something Slaoui and his team thought they had clearly explained.

“Every single time we said, ‘We will produce enough vaccine doses to immunize the U.S. population by the summer of 2021.’ It is understood in that statement that it’s going to take six, seven months to have enough vaccine to immunize everybody,” he said. “But, in fact, I think we should have communicat­ed much, much better that there will not be enough vaccine for everybody immediatel­y.”

It’s going to take time to overcome that deficit of trust and informatio­n, said Dr. Kelly Moore, deputy director of the nonprofit Immunizati­on Action Coalition.

“We will never recapture the opportunit­ies that were lost to build a solid foundation for the vaccinatio­n program before vaccines began rolling out,” she said, “but we’re getting back on track, and the signs give me hope.”

 ?? JOHN LOCHER/AP ?? Empty vials of Pfizer-BioNTech COVID-19 vaccine at the University of Nevada, Las Vegas on Jan. 22.
JOHN LOCHER/AP Empty vials of Pfizer-BioNTech COVID-19 vaccine at the University of Nevada, Las Vegas on Jan. 22.

Newspapers in English

Newspapers from United States